Pasar al contenido principal

Restaurando el balance: mediadores proresolutivos especializados para la resolución de la inflamación y la reparación vascular en humanos con alto riesgo cardiovascular

AC23_2/00044

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal para Afrontar las Prioridades de Nuestro Entorno
Subprograma Subprograma Estatal de Internacionalización
Convocatoria Proyectos de Colaboracion Internacional
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INVESTIGACION BIOMEDICA HOSPITAL LA PAZ
Centro realización INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO LA PAZ (IdiPAZ)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction

  • Briones, Ana|||0000-0001-8218-5579
  • Hernanz, Raquel
  • Garcia Redondo, Ana B.|||0000-0002-5815-3320
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Blanco-Colio, Luis Miguel|||0000-0002-1560-6609
  • Val-Blasco, Almudena
  • Alonso, María Jesús|||0000-0003-4912-1121
  • Salaices Sanchez, Mercedes|||0000-0003-3323-1692
Excessive local inflammation is a common mechanism in many cardiovascular diseases (CVDs) such as hypertension, atherosclerosis and aortic aneurysms. In endothelial cells, inflammatory cytokines such as interferons, tumour necrosis factor alpha or interleukins increase oxidative stress and contractile prostanoids and the expression of adhesion molecules that reduce nitric oxide (NO) availability and bind leucocytes, thereby impairing endothelial function. Despite this evidence, anti-inflammatory therapies are not yet indicated for the treatment of most CVD. Resolution of inflammation is mediated by a family of specialized pro-resolving mediators (SPMs) that act on cognate G protein-coupled receptors to limit immune cell infiltration and initiate tissue repair. SPMs, generated from omega-3 and omega-6 polyunsaturated fatty acids, belong to four major families: lipoxins, resolvins, protectins and maresins. SPM receptors are expressed in immune and vascular cells where they regulate important processes such as phagocytosis and polarization, production of cytokines, NO and prostacyclin, and modulation of smooth muscle cell phenotype. Growing evidence in animal models demonstrates that activation of SPM receptors can protect vascular function and structure and provide beneficial effects in various CVD. We will review recent advances in the role of inflammation and SPMs in vascular (dys)function in hypertension, atherosclerosis, and aortic aneurysms.